Evidence map›Paper›PMID 37503745›Full record

ReviewInternational journal of molecular medicine2023

Navigating paediatric virology through the COVID‑19 era (Review).

Ioannis N Mammas, Simon B Drysdale, Charalampos Charalampous, Patra Koletsi, Alexia Papatheodoropoulou, Chryssie Koutsaftiki, Theodoros Sergentanis, Kyriakoula Merakou, Helen Kornarou, Georgia Papaioannou and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 5 countries.

Ioannis N MammasDepartment of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.
Simon B DrysdaleCentre for Neonatal and Paediatric Infection, St. George's, University of London, London SW17 0RE, UK.
Charalampos CharalampousKliniken Maria Hilf GmbH, 41063 Mönchengladbach, Germany.
Patra KoletsiDepartment of Paediatrics, 'Penteli' Children's Hospital, 15236 Palaia Penteli, Greece.
Alexia PapatheodoropoulouPaediatric Intensive Care Unit (PICU), University Hospital of Patras, 26504 Rio, Greece.
Chryssie KoutsaftikiCOVID‑19 Reference Centre, 'Rafina' Health Care Centre, 19009 Rafina, Greece.
Theodoros SergentanisDepartment of Public Health Policy, School of Public Health, University of West Attica, 11521 Athens, Greece.
Kyriakoula MerakouDepartment of Public Health Policy, School of Public Health, University of West Attica, 11521 Athens, Greece.
Helen KornarouDepartment of Public Health Policy, School of Public Health, University of West Attica, 11521 Athens, Greece.
Georgia PapaioannouDepartment of Paediatric Radiology, 'Mitera' Children's Hospital, 15123 Athens, Greece.
Anna KramvisHepatitis Virus Diversity Research Unit, Department of Internal Medicine, School of Clinical Medicine, University of the Witwatersrand, 2193 Johannesburg, South Africa.
Anne GreenoughDivision of Asthma, Allergy and Lung Biology, King's College London, London SE5 9RS, UK.
Maria TheodoridouFirst Department of Paediatrics, School of Medicine, University of Athens, 11527 Athens, Greece.
Demetrios A SpandidosDepartment of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.
University of West Attica · GRUniversity of Crete · GRCentre Casa · CAGeneral University Hospital of Patras · GRKing's College London · GBKliniken Maria Hilf · DEMitera Hospital · GRNational and Kapodistrian University of Athens · GRPenteli General Children's Hospital · GRSt George's, University of London · GBUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present review article presents the key messages of the 8th Workshop on Paediatric Virology organised virtually by the Institute of Paediatric Virology based on the island of Euboea in Greece. The major topics covered during the workshop were the following: i) New advances in antiviral agents and vaccines against cytomegalovirus; ii) hantavirus nephropathy in children; iii) human rhinovirus infections in children requiring paediatric intensive care; iv) complications and management of human adenovirus infections; v) challenges of post‑coronavirus disease 2019 (COVID‑19) syndrome in children and adolescents; and vi) foetal magnetic resonance imaging in viral infections involving the central nervous system. The COVID‑19 era requires a more intensive, strategic, global scientific effort in the clinic and in the laboratory, focusing on the diagnosis, management and prevention of viral infections in neonates and children.

Indexed as

COVID-19Virus DiseasesAdolescentAntiviral AgentsChildCytomegalovirusGreeceHumansInfant, NewbornAntiviral Agentsadenovirusantiviral agentschildrencytomegalovirushantavirusmagnetic resonance imagingpaediatric virologypost‑COVID‑19rhinovirusvaccines

Identifiers

PMID37503745
PMCPMC10555476
OpenAlexW4385318982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.